Tenax TherapeuticsTENX
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 49 institutions reported holding Tenax Therapeutics Inc. (TENX) in their 13F filings, up 15 from Q3 2025. 18 opened new positions and 5 sold out. The largest holders were Ikarian Capital, LLC ($11.8M), Morgan Stanley ($7.3M) and Perceptive Advisors LLC ($5.4M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Tenax Therapeutics Inc.
- CUSIP
- 88032L605
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $21.1M |
| Exits | 5 | $3.5M |
All 13F filers, Q3 2025 → Q4 2025: 2,700,110 shares bought and 471,886 shares sold, net +2,228,224 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Ikarian Capital, LLC | 1.53% | No change | 967,600 | $11.8M |
| Morgan Stanley | 0.00% | Add +234.4% | 596,376 | $7.3M |
| Perceptive Advisors LLC | 0.10% | New | 439,142 | $5.4M |
| Siren, L.L.C. | 0.16% | Add +21.2% | 427,141 | $5.2M |
| Point72 Asset Management | 0.01% | New | 423,415 | $5.2M |
| RTW Investments, LP | 0.05% | No change | 378,346 | $4.6M |
| Boothbay Fund Management, LLC | 0.11% | No change | 352,206 | $4.3M |
| BVF Inc. | 0.14% | No change | 339,549 | $4.1M |
| Millennium Management | 0.00% | Reduce -3.6% | 302,473 | $3.7M |
| Marshall Wace, LLP | 0.00% | Add +68.3% | 298,153 | $3.6M |
| Vanguard Group Inc. | 0.00% | Add +58.0% | 255,664 | $3.1M |
| Diadema Partners LP | 1.77% | New | 243,170 | $3.0M |
| Vivo Capital, LLC | 0.16% | No change | 208,333 | $2.5M |
| Sphera Funds Management LTD. | 0.48% | New | 190,111 | $2.3M |
| Integral Health Asset Management, LLC | 0.10% | No change | 167,000 | $2.0M |
| Janus Henderson Group PLC | 0.00% | No change | 166,666 | $2.0M |
| Woodline Partners LP | 0.01% | Add +62.7% | 143,481 | $1.7M |
| FMR LLC | 0.00% | New | 141,100 | $1.7M |
| Citadel Advisors | 0.00% | Add +199.5% | 129,528 | $1.6M |
| Renaissance Technologies | 0.00% | Add +121.9% | 125,579 | $1.5M |
| Deeter Investments LLP | 0.26% | — | 100,000 | $1.2M |
| Velan Capital Investment Management LP | 0.59% | No change | 83,333 | $1.0M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 83,333 | $1.0M |
| Persistent Asset Partners Ltd | 0.38% | New | 65,272 | $796K |
| ADAR1 Capital Management, LLC | 0.06% | Add +19.2% | 63,673 | $776K |
| Geode Capital Management, LLC | 0.00% | Add +61.8% | 55,699 | $679K |
| Vestal Point Capital, LP | 0.02% | No change | 53,439 | $651K |
| Bridgeway Capital Management, LLC | 0.01% | New | 44,900 | $547K |
| Artia Global Partners LP | 0.08% | New | 42,080 | $513K |
| Two Sigma Investments, LP | 0.00% | New | 33,470 | $408K |
| Goldman Sachs Group Inc. | 0.00% | New | 22,409 | $273K |
| Quadrature Capital Ltd | 0.00% | New | 20,648 | $252K |
| BlackRock, Inc. | 0.00% | Add +5452.8% | 16,714 | $204K |
| BNP Paribas Financial Markets | 0.00% | New | 15,296 | $186K |
| Two Sigma Advisers, LP | 0.00% | New | 13,178 | $161K |
| Corient Private Wealth LP | 0.00% | New | 12,388 | $151K |
| Stonepine Capital Management, LLC | 0.11% | New | 11,884 | $145K |
| Letko, Brosseau & Associates Inc. | 0.00% | New | 10,650 | $130K |
| Bank of America Corp. | 0.00% | Add +1388.2% | 3,780 | $46K |
| JPMorgan Chase & Co. | 0.00% | New | 902 | $11K |
| UBS Group AG | 0.00% | Add +468.1% | 676 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -60.3% | 199 | $2K |
| Allworth Financial LP | 0.00% | No change | 1 | $13 |
| Physician Wealth Advisors, Inc. | 0.00% | No change | 1 | $13 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $12 |
| Citigroup Inc. | 0.00% | New | 1 | $12 |
| Rockefeller Capital Management L.P. | 0.00% | Reduce -50.0% | 1 | $12 |
| Titiun Yejiel | 0.00% | — | 1 | $12 |
| Union Bancaire Privee, UBP SA | 0.00% | No change | 1 | $9 |
"% of holder's portfolio" is TENX's weight in each manager's 13F, not the share of Tenax Therapeutics Inc. the manager owns.